A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...

During the discussion, he explained what he wants patients to understand about participating in clinical trials for their gastrointestinal cancers. Additionally, he imparted key updates from this ...

Simon Spichak finished his MSc at University College Cork, where he studied the interactions between the microbes in the gut and the brain. He became interested in science communication during his ...

Many people are surprised to learn that clinical trials aren't just for people who have run out of standard treatment options, but are an important part of cancer care at every stage and most aspects ...

Many people are surprised to learn that clinical trials aren't just for people who have run out of standard treatment options, but are an important part of cancer care at every stage and most aspects ...

When discussing the future of clinical trials, people often focus on the promise of exciting new technologies, including artificial intelligence (AI) and predictive modeling. However, even the most ...

AI promised to speed up drug discovery, but the real bottleneck is in clinical trials. This startup is using AI to accelerate ...

Advocate Health is scaling clinical trial network across six states to integrate research into routine care at ...

Share on Pinterest Actor Rob Lowe has teamed up with Eli Lilly to encourage more people to participate in cancer clinical trials. Photography courtesy of Rob Lowe Rob Lowe shares how three generations ...

The viewpoint reviews conflicting evidence on alcohol consumption, highlighting discrepancies between observational studies, ...

Experts say a lack of participation in clinical trials is one reason Black women are 38% more likely to die from breast cancer. A simple question sparked complicated answers: “Would you participate in ...